This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Nishiwaki S, Nakayama T, Murata M, Nishida T, Sugimoto K, Saito S, et al. Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy. Int J Hematol. 2012;95(4):428–33.
Sakaguchi H, Matsumoto K, Yoshida N, Narita K, Hamada M, Kataoka S, et al. Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy. Bone Marrow Transpl. 2016;51(11):1540–2.
Takagi S, Masuoka K, Uchida N, Ishiwata K, Araoka H, Tsuji M, et al. High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults. Br J Haematol. 2009;147(4):543–53.
We thank the staff of the hematopoietic stem cell transplantation team at Okayama University Hospital.
Conflict of interest
The authors declare that they have no conflict of interest. A summary of relevant information will be published with the manuscript.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Sugiura, H., Matsuoka, Ki., Matsuda, M. et al. Macrophage elimination in bone marrow by dexamethasone palmitate is associated with successful engraftment in patients with hemophagocytic syndrome. Int J Hematol 110, 260–262 (2019). https://doi.org/10.1007/s12185-019-02659-1
- Hemophagocytic syndrome
- Dexamethasone palmitate